In this retrospective cohort of Taiwanese patients with glaucoma whose IOP remained inadequately controlled on prior PGAs therapy, switching to LBN was associated with a statistically significant, although modest, reduction in IOP over 12 months and a low rate of mild, non-serious ocular adverse events. These exploratory real-world findings provide hypothesis-generating evidence supporting LBN as a treatment option when further IOP reduction is needed and should be confirmed in larger prospective multicenter studies.
Chiu et al. (Fri,) studied this question.